Logo image
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Journal article   Open access   Peer reviewed

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

Brian T. Tsuji, Jason M. Pogue, Alexandre P. Zavascki, Mical Paul, George L. Daikos, Alan Forrest, Daniele R. Giacobbe, Claudio Viscoli, Helen Giamarellou, Ilias Karaiskos, …
Pharmacotherapy, v 39(1)
Jan 2019
PMID: 30710469
url
https://doi.org/10.1002/phar.2209View
Published, Version of Record (VoR)Maybe Open Access (Publisher Bronze) Open

Abstract

ESI Highly Cited Paper (Incites)

Metrics

20 Record Views
767 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Highly Cited Paper 
Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Pharmacology & Pharmacy
Logo image